Aptevo Therapeutics (APVO) vs Clearmind Medicine (CMND)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clearmind Medicine is the larger company by market cap ($3.3 million vs $3.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APVO | CMND |
|---|---|---|
| Share price | $1.80 | $6.60 |
| Market cap | $3.26M | $3.35M |
| 1-day change | -2.17% | 0.00% |
| P/E ratio (TTM) | 0.03 | — |
| EPS (TTM) | $66.96 | $-461.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.14 | $3,840.00 |
| 52-week low | $1.37 | $5.25 |
| Distance from 52-week high | -94.22% | -99.83% |
| Analyst consensus | none | — |
| Avg. price target upside | +1316.67% | — |
| Average volume | 91.51K | 70.89K |
| Shares outstanding | 1.81M | 507.40K |
| Employees | 33 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aptevo Therapeutics
APVO stock →Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.
Healthcare · Biotechnology · 33 employees
About Clearmind Medicine
CMND stock →Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression.
Healthcare · Biotechnology
APVO vs CMND FAQ
Which is bigger, Aptevo Therapeutics or Clearmind Medicine?
Clearmind Medicine (CMND) is larger, with a market capitalization of $3.35M compared with $3.26M for Aptevo Therapeutics (APVO).
Are Aptevo Therapeutics and Clearmind Medicine in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.